Nuscale Power Corporation vs 22nd Century Group Inc — how do they compare? Nuscale Power Corporation trades at $7.19 (market cap $3.00B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Nuscale Power Corporation is far larger — about 4825.7× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 43,143,109). Which is the better fit depends on your goals — on Pluang, investors hold Nuscale Power Corporation for 29 Days and 22nd Century Group Inc for 32 Days on average.
| SMR | XXII | |
|---|---|---|
Market Cap | $3.00B | $621.67K |
Volume | 43,143,109 | 45,625 |
Sector | Industrials | Consumer Staples |
52-Week High | $53.43 | $483.00 |
52-Week Low | $7.32 | $0.80 |
Typical Hold Time | 29 Days | 32 Days |
Enterprise Value | $1.93B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
NuScale Power (SMR) trades at $7.20, down 6.13% with bearish technical signals. The company shows concerning fundamentals with negative net income margins (-3,888.7% in 2026) despite analyst consensus of $11.25 price target. Recent news highlights ongoing investor investigations and competitive pressures in the nuclear energy sector.
While analysts maintain 50% buy ratings, significant operational losses and cash burn create substantial risk. The stock faces headwinds from execution challenges and dilution concerns, though long-term nuclear energy adoption trends provide potential upside for patient investors.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →